ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 635 filers reported holding ISHARES TR in Q4 2017. The put-call ratio across all filers is 2.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $350,000 | -2.5% | 2,585 | -1.6% | 0.16% | +8.7% |
| Q2 2020 | $359,000 | -39.6% | 2,627 | -52.4% | 0.15% | -50.3% |
| Q1 2020 | $594,000 | +5.5% | 5,515 | +18.0% | 0.30% | +30.7% |
| Q4 2019 | $563,000 | -0.2% | 4,672 | -17.6% | 0.23% | -6.5% |
| Q3 2019 | $564,000 | -14.7% | 5,672 | -6.4% | 0.25% | -16.0% |
| Q2 2019 | $661,000 | -2.5% | 6,062 | 0.0% | 0.29% | -5.5% |
| Q1 2019 | $678,000 | +15.9% | 6,062 | 0.0% | 0.31% | +1.3% |
| Q4 2018 | $585,000 | -20.8% | 6,062 | 0.0% | 0.31% | -13.3% |
| Q3 2018 | $739,000 | +24.4% | 6,062 | +12.0% | 0.35% | +19.2% |
| Q2 2018 | $594,000 | +2.4% | 5,411 | -0.5% | 0.30% | +0.3% |
| Q1 2018 | $580,000 | +39.8% | 5,439 | +41.9% | 0.30% | -19.8% |
| Q4 2017 | $415,000 | -10.9% | 3,833 | +179.0% | 0.37% | -18.9% |
| Q3 2017 | $466,000 | -4.1% | 1,374 | -12.5% | 0.46% | +2.5% |
| Q2 2017 | $486,000 | -3.6% | 1,571 | -10.5% | 0.44% | -5.3% |
| Q1 2017 | $504,000 | – | 1,755 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |